Clinical Trials

    Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    Investigator: Eleni Efstathiou

    Study Coordinator: Derek Cole

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT03574571

    Phone: 713.441.5607

    Protocol Number: Pro00022762

    Description


    The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.